etofibrate has been researched along with Arteriosclerosis in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Santafé Oroz, J; Segarra Domènech, J | 1 |
Díaz Méndez, M; Priego, JG | 1 |
Degenring, FH; Hotz, W; Schatton, W | 1 |
Göhmann, E; Mertz, DP; Suermann, I | 1 |
Benadé, AJ; Fincham, JE; Quack, G; Wülfroth, P | 1 |
Sinzinger, H | 1 |
Chelstowski, K; Jastrzebska, M; Kopciewicz, J; Naruszewicz, M; Pieczul-Mróz, J; Torbus-Lisiecka, B | 1 |
Fenselau, S; Schrezenmeir, J; Steinmetz, A | 1 |
Betz, E; Quack, G | 1 |
Ojeda, G; Portolés, A; Portolés, MP; Rojo, JM | 1 |
Betz, E; Hämmerle, H | 1 |
3 review(s) available for etofibrate and Arteriosclerosis
Article | Year |
---|---|
[Pharmacologic therapy of atherosclerosis (I). Current possibilities].
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Gemfibrozil; Glycosaminoglycans; Humans; Ion Exchange Resins; Lipoproteins; Nicotinic Acids; Pentanoic Acids; Probucol | 1983 |
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibrinolysis; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Thrombosis | 1998 |
Treatment of dyslipoproteinemia in the metabolic syndrome.
Topics: Arteriosclerosis; Clofibric Acid; Coronary Disease; Diabetes Mellitus, Type 2; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Metabolic Syndrome | 2001 |
1 trial(s) available for etofibrate and Arteriosclerosis
Article | Year |
---|---|
Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
Topics: Arteriosclerosis; Clofibric Acid; Diabetes Mellitus, Type 1; Factor VII; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects; Risk Factors; Statistics, Nonparametric | 1999 |
7 other study(ies) available for etofibrate and Arteriosclerosis
Article | Year |
---|---|
[Pharmacologic therapy of arteriosclerosis: current possibilities].
Topics: Anticholesteremic Agents; Arteriosclerosis; Clofibrate; Clofibric Acid; Humans | 1984 |
[Atherosclerosis treatment with etofibrate retard. New perspectives].
Topics: Arteriosclerosis; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Female; Hemodynamics; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides; Uric Acid | 1983 |
[Etofibrate lowers the atherosclerosis index].
Topics: Arteriosclerosis; Clofibrate; Clofibric Acid; Humans; Lipids | 1981 |
Confirmation of efficacy of etofibrate against peripheral atherosclerosis in non-human primates which model human lesion types I-VII.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Body Weight; Chlorocebus aethiops; Clofibric Acid; Coronary Vessels; Diet, Atherogenic; Eating; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Organ Size | 1996 |
Effect of etofibrate on the development and the regression of atheromas in a rabbit model of atherosclerosis.
Topics: Animals; Arteriosclerosis; Clofibrate; Clofibric Acid; Disease Models, Animal; Hypolipidemic Agents; Rabbits | 1990 |
Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes.
Topics: Anaphylaxis; Animals; Antibody Formation; Antigen-Antibody Complex; Arteriosclerosis; Clofibrate; Clofibric Acid; Cyclic AMP; Cyclic GMP; Female; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Niacin; Thiophenes; Ticlopidine | 1985 |
Effect of etofibrate and its metabolites on atheromas of rabbits and on smooth muscle cell cultures.
Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Carotid Arteries; Cell Division; Cells, Cultured; Cholesterol; Cholesterol, Dietary; Clofibrate; Clofibric Acid; Clone Cells; Electric Stimulation; Fibroblasts; Lipoproteins, HDL; Male; Muscle, Smooth, Vascular; Rabbits; Triglycerides | 1986 |